Dr. Parameswaran N. Hari, MD

Dr. Hari practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Hari's NPI, 1083665814, was assigned on May 15, 2006. Dr. Hari graduated from University of Kerala Medical College in 1992. Dr. Hari's Wisconsin license number on file is 44360.

Dr. Hari's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Hari's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hari practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hari is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hari has a license on file in Wisconsin.

CMS data shows 42 Medicare services from Dr. Hari across 1 procedure code in 2022. Medicare paid $6,710 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Hari's median patient age at 70, with 44% women.

In 2021, Dr. Hari wrote 270 Medicare Part D claims. They cover 12 drugs, with $34,265 in total drug cost. In 2020, CMS named 279 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Hari for performance year 2024, reported as part of a group. Dr. Hari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 348 papers to Dr. Hari, published from 2006 to 2025. 2020 was the busiest year, with 40. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Transplantation, Autologous. Dr. Hari has published most often in Biol Blood Marrow Transplant. Dr. Hari's most frequent co-authors are Saurabh Chhabra, MD, Binod Dhakal, MD and Anita D'Souza, MD.

Dmand AI links Dr. Hari to 23 clinical trials, 5 of them phase 1/2 studies. 6 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Anemia, Aplastic. AbbVie sponsors the most, 3. Open Payments lists research payments to Dr. Hari that name 7 trials.

CMS Open Payments shows 694 general payments to Dr. Hari from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Pfizer Inc. paid the most, $796,238. It also lists 78 research payments totaling $625,877 from 2016 to 2025, naming 7 clinical trials.

Dmand AI lists 2 awards for Dr. Hari, most recently Regional Top Doctor in 2014.

Dr. Hari graduated from University of Kerala Medical College in 1992.

Dr. Hari is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.